Analysis of Vascular Smooth Muscle Cells from Thoracic Aortic Aneurysms Reveals DNA Damage and Cell Cycle Arrest as Hallmarks in Bicuspid Aortic Valve Patients.
Ariadna Martin-BlazquezMarta Martin-LorenzoAranzazu Santiago-HernandezAngeles HerederoAlicia DonadoJuan A LopezMiriam Anfaiha-SanchezRocio Ruiz-JimenezVanesa EstebanJesus VazquezGonzalo Aldamiz-EchevarriaGloria Álvarez-LlamasPublished in: Journal of proteome research (2024)
Thoracic aortic aneurysm (TAA) is mainly sporadic and with higher incidence in the presence of a bicuspid aortic valve (BAV) for unknown reasons. The lack of drug therapy to delay TAA progression lies in the limited knowledge of pathophysiology. We aimed to identify the molecular hallmarks that differentiate the aortic dilatation associated with BAV and tricuspid aortic valve (TAV). Aortic vascular smooth muscle cells (VSMCs) isolated from sporadic TAA patients with BAV or TAV were analyzed by mass spectrometry. DNA oxidative damage assay and cell cycle profiling were performed in three independent cohorts supporting proteomics data. The alteration of secreted proteins was confirmed in plasma. Stress phenotype, oxidative stress, and enhanced DNA damage response (increased S-phase arrest and apoptosis) were found in BAV-TAA patients. The increased levels of plasma C1QTNF5, LAMA2, THSB3, and FAP confirm the enhanced stress in BAV-TAA. Plasma FAP and BGN point to an increased inflammatory condition in TAV. The arterial wall of BAV patients shows a limited capacity to counteract drivers of sporadic TAA. The molecular pathways identified support the need of differential molecular diagnosis and therapeutic approaches for BAV and TAV patients, showing specific markers in plasma which may serve to monitor therapy efficacy.
Keyphrases
- aortic valve
- end stage renal disease
- aortic stenosis
- oxidative stress
- transcatheter aortic valve replacement
- ejection fraction
- mass spectrometry
- vascular smooth muscle cells
- chronic kidney disease
- dna damage
- aortic valve replacement
- newly diagnosed
- cell cycle
- prognostic factors
- cell death
- peritoneal dialysis
- spinal cord
- angiotensin ii
- dna damage response
- left ventricular
- cell cycle arrest
- coronary artery disease
- high resolution
- emergency department
- heart failure
- pulmonary hypertension
- pulmonary artery
- patient reported outcomes
- atrial fibrillation
- electronic health record
- muscular dystrophy
- high performance liquid chromatography
- simultaneous determination
- drug induced